| Classification | Prescription drugs |
|---|---|
| Active Ingredients | Leuprolide acetate (Leuprorelin) 3.75 mg/mL, 7.5 mg/mL or 11.25 mg/mL |
| Efficacy and Effect | 1. Prostatic cancer 2. Endometriosis 3. Premenopausal breast cancer 4. Reduction of myoma nucleus and improvement of symptom in uterine myoma accompanied with hypermenorrhea, hypogastrium ache, lumbago, and/or anemia 5. Central precocious puberty |
| Packing Unit | 3.75 mg: 1 vial with attached ampoule for solvent / box 7.5 mg: 1 vial with attached ampoule for solvent / box (not for sale in Korea) 11.25 mg: 1 vial with attached ampoule for solvent / box (not for sale in Korea) |
| Storage Method | Keep in the tight container at room temperature(1-30°C) |
| Shelf Life | 36 months from manufacturing date |